Con esta herramienta te facilitamos un acceso a todas las ofertas y demandas de tecnología europeas y a búsquedas de socios para participar en propuestas europeas de I+D publicadas en la red Enterprise Europe Network, pudiendo filtrar los resultados para facilitar las búsquedas más acordes con tus necesidades.

¿Quieres recibir estos listados de oportunidades de colaboración en tu correo de forma periódica y personalizada? Date de alta en nuestro Boletín

Para optimizar los resultados de la búsqueda, se recomienda utilizar términos en inglés.

H2020. Medicina regenerativa. Búsqueda de socios con experiencia en inmunología/patología vascular o aplicaciones basadas en catéter intravascular y toxicología

Resumen

Tipo:
Búsqueda de socios
Referencia:
RDDE20190128001
Publicado:
30/01/2019
Caducidad:
22/02/2019
Resumen:
Un laboratorio de investigación alemán busca socios industriales e investigadores con experiencia en aplicaciones basadas en catéter intravascular, toxicología e inmunología y patología vascular para participar en un proyecto dentro de la convocatoria de Medicina Regenerativa del programa H2020: desde nuevos conocimientos hasta nuevas aplicaciones. El objetivo del proyecto es desarrollar un método de prevención de la dilatación patológica de la aorta en caso de aneurisma. El laboratorio inducirá la regeneración de elastina para finalmente estabilizar las secciones del vaso sanguíneo afectado. La fecha límite de la convocatoria es el 16 de abril de 2019 y el plazo para presentar expresiones de interés finaliza el 22 de febrero. El presupuesto es de 6 millones de euros.

Details

Tittle:
H2020 - Regenerative Medicine - Partners with expertise in vascular immunology/pathology or intravascular catheter-based applications and toxicology required
Summary:
A German research laboratory looks for industrial and research partners experienced in intravascular catheter-based application, toxicology, vascular wall immunology and pathology for a project under the H2020 call Regenerative medicine: from new insights to new applications. Aim of the project is to develop a method for preventing the pathologic dilatation of the aorta in case of aneurysms. The laboratory will induce the regeneration of elastin to finally stabilize the affected vessel sections.
Description:
Due to demographic change and the associated increase of elderly and multimorbid patients, an increase in thoracic and abdominal aortic aneurysm cases is to be expected. The current therapy is a continuous monitoring of progression. The inevitable progression of the disease increases the risk of rupture of the affected vessel over time. The rupture of the aorta often leads to strong and usually insatiable bleeding and can be fatal. Therefore, after reaching a diameter of > 5 cm, a preventive surgical procedure is required.

In order to tackle this problem a research laboratory of German university hospital is going to submit a proposal under the H2020 call SC1-BHC-07-2019 - Regenerative medicine: from new insights to new applications.
In this project, the research laboratory aims to induce the regeneration of elastin to stabilize the affected vessel wall. For this purpose, using the elastase-induced aneurysm model in rabbits, the stabilization of aneurysms and the progression will be investigated after the local administration of synthetic elastin-encoding mRNA (messenger RNA. Therefore, the synthetic mRNA complexed with a suitable transport vehicle is administered locally into the aorta and the protein synthesis of elastin is detected in elastase-induced aneurysm model in rabbits. At the beginning and 4 weeks after mRNA application, the change in vessel diameter is determined by sonography and angiography. Furthermore, treated vessel sections are examined histologically and by using ELISA (Enzyme-linked Immunosorbent Assay) and proteomics the production of elastin, immune responses, and change of tissue physiology are analyzed. The described project represents a promising method for preventing the pathologic dilatation of aorta and could make a severe surgery unnecessary and minimize the risk of rupture in the long term.

The laboratory is looking for partners for a reasearch co-operation agreement with expertise in:
-Intravascular catheter-based application
-Toxicologists in the above field
-Vascular wall immunology: specifically, TLR (toll-like receptor) activation
-Vessel wall pathology

Partners can be from academia and industry, SMEs with relevant track records in the respective fields are welcome.
It would also be suitable if one organisation has expertise in several tasks.

Deadline of the call - 16 April 2019
RIA Research and Innovation action
Budget - up to 6 million Euro
Deadline for expressions of interest - 22 February 2019

Stage of Development:
Proposal under development
IPR Status:
Granted patent or patent application essential

Partner sought

Partner Sought:
Partners from academia and industry, also SMEs. They could be -Specialists in intravascular catheter-based application -Toxicologists -Vascular wall immunologists: specifically, TLR (toll-like receptor) activation -Vessel wall pathologists
Type of Partnership Considered:
RDR

Client

Type and Size of Client:
R-Y-D Institution
Already Engaged in Trans-National Cooperation:
Si
Languages Spoken:
English
German

Dissemination

Programme-call

Framwork Programme:
Societal challenges
Evaluation Scheme:
single-stage
Coordinator Required:
No
Deadline for Call:
16/04/2019